Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trialsBirgit Sawitzki, Tewfik Miloud, Régis Josien et al.|The Lancet|2020Cited by 445
Vascular Endothelial Growth Factor Gene Polymorphisms Are Associated with Acute Renal Allograft RejectionMajid Shahbazi, Paul Harden, Anthony A. Fryer et al.|Journal of the American Society of Nephrology|2002Cited by 412
Non-melanoma skin cancer risk in the Queensland renal transplant populationHelen Ramsay, Paul Harden, Anthony A. Fryer et al.|British Journal of Dermatology|2002Cited by 280
Clinical risk factors associated with nonmelanoma skin cancer in renal transplant recipientsHelen Ramsay, Paul Harden, Anthony A. Fryer et al.|American Journal of Kidney Diseases|2000Cited by 235
Incidence and prediction of nonmelanoma skin cancer post-renal transplantation: A prospective study in Queensland, AustraliaRobert Carroll, Paul Harden, Anthony A. Fryer et al.|American Journal of Kidney Diseases|2003Cited by 136